Itron, Inc. (NASDAQ:ITRI) Given Consensus Rating of “Hold” by Analysts

Itron, Inc. (NASDAQ:ITRI) has been assigned a consensus recommendation of “Hold” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $68.70.

A number of research analysts recently issued reports on ITRI shares. StockNews.com upgraded Itron from a “buy” rating to a “strong-buy” rating in a report on Tuesday, August 29th. Argus upgraded Itron from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a report on Friday, August 18th. JPMorgan Chase & Co. upped their target price on Itron from $54.00 to $64.00 in a report on Wednesday, July 19th. Raymond James downgraded Itron from a “strong-buy” rating to an “outperform” rating and upped their target price for the stock from $70.00 to $81.00 in a report on Wednesday, July 12th. Finally, Robert W. Baird upped their target price on Itron from $63.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, August 4th.

Itron Stock Down 1.6 %

ITRI opened at $64.33 on Friday. The company has a market cap of $2.92 billion, a P/E ratio of 75.68 and a beta of 1.36. The business’s 50-day moving average price is $71.03 and its 200-day moving average price is $63.92. The company has a current ratio of 1.73, a quick ratio of 1.26 and a debt-to-equity ratio of 0.37. Itron has a 12 month low of $39.38 and a 12 month high of $79.99.

Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Thursday, August 3rd. The scientific and technical instruments company reported $0.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.34. Itron had a return on equity of 8.02% and a net margin of 2.01%. The company had revenue of $541.07 million for the quarter, compared to the consensus estimate of $518.01 million. On average, equities analysts expect that Itron will post 2.16 EPS for the current year.

Insider Transactions at Itron

In related news, SVP Donald L. Reeves III sold 983 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $78.00, for a total value of $76,674.00. Following the transaction, the senior vice president now directly owns 9,091 shares of the company’s stock, valued at approximately $709,098. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.47% of the company’s stock.

Hedge Funds Weigh In On Itron

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. lifted its position in Itron by 3.3% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,697 shares of the scientific and technical instruments company’s stock valued at $6,138,000 after acquiring an additional 3,544 shares in the last quarter. Natixis Advisors L.P. raised its stake in Itron by 3.3% during the 1st quarter. Natixis Advisors L.P. now owns 28,034 shares of the scientific and technical instruments company’s stock valued at $1,554,000 after buying an additional 894 shares during the last quarter. Federated Hermes Inc. raised its stake in Itron by 54.5% during the 1st quarter. Federated Hermes Inc. now owns 295,527 shares of the scientific and technical instruments company’s stock valued at $16,387,000 after buying an additional 104,199 shares during the last quarter. FDx Advisors Inc. raised its stake in Itron by 5.8% during the 4th quarter. FDx Advisors Inc. now owns 5,687 shares of the scientific and technical instruments company’s stock valued at $288,000 after buying an additional 314 shares during the last quarter. Finally, Peregrine Capital Management LLC raised its stake in Itron by 3.1% during the 1st quarter. Peregrine Capital Management LLC now owns 154,342 shares of the scientific and technical instruments company’s stock valued at $8,558,000 after buying an additional 4,573 shares during the last quarter. 95.12% of the stock is owned by institutional investors.

Itron Company Profile

Itron, Inc, a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. It operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.